{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:02:25Z","timestamp":1782864145886,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Yangzhou Municipal Science and Technology Bureau","award":["No. YZ2024091"],"award-info":[{"award-number":["No. YZ2024091"]}]},{"name":"the Yangzhou Municipal Science and Technology Bureau","award":["No. YZ2024098"],"award-info":[{"award-number":["No. YZ2024098"]}]},{"name":"the Yangzhou Municipal Science and Technology Bureau","award":["No. YZ2025076"],"award-info":[{"award-number":["No. YZ2025076"]}]},{"name":"the Clinical Research Program of Northern Jiangsu People\u2019s Hospital","award":["SBLC25003"],"award-info":[{"award-number":["SBLC25003"]}]},{"name":"the Young Talent Support Program of Northern Jiangsu People\u2019s Hospital","award":["SBQN25009"],"award-info":[{"award-number":["SBQN25009"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82371336"],"award-info":[{"award-number":["No. 82371336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"Chinese Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["No. 2022M711426"],"award-info":[{"award-number":["No. 2022M711426"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Eighth Batch Support Program for Key Clinical Technologies of Northern Jiangsu People\u2019s Hospital","award":["FCJS202509"],"award-info":[{"award-number":["FCJS202509"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04889-0","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:27:53Z","timestamp":1778110073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma YAP1 as a biomarker for the prediction of occurrence, progression, and outcomes of sepsis-associated liver injury: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jun","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aipeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianfang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"8","key":"4889_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"10219","key":"4889_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"issue":"3","key":"4889_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1872-034X.2012.01069.x","volume":"43","author":"H Kobashi","year":"2013","unstructured":"Kobashi H, Toshimori J, Yamamoto K. Sepsis-associated liver injury: incidence, classification and the clinical significance. Hepatol Res. 2013;43(3):255\u201366. https:\/\/doi.org\/10.1111\/j.1872-034X.2012.01069.x.","journal-title":"Hepatol Res"},{"issue":"1","key":"4889_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55\u201366. https:\/\/doi.org\/10.1038\/nrgastro.2016.168.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4889_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s10020-022-00510-8","volume":"28","author":"D Beyer","year":"2022","unstructured":"Beyer D, Hoff J, Sommerfeld O, Zipprich A, Gassler N, Press AT. The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation. Mol Med. 2022;28(1):84. https:\/\/doi.org\/10.1186\/s10020-022-00510-8.","journal-title":"Mol Med"},{"issue":"1","key":"4889_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s13054-020-03327-1","volume":"24","author":"J Sun","year":"2020","unstructured":"Sun J, Zhang J, Wang X, Ji F, Ronco C, Tian J, Yin Y. Gut-liver crosstalk in sepsis-induced liver injury. Crit Care. 2020;24(1):614. https:\/\/doi.org\/10.1186\/s13054-020-03327-1.","journal-title":"Crit Care"},{"key":"4889_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1504223","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo Y, Guo W, Chen H, Sun J, Yin Y. Mechanisms of sepsis-induced acute liver injury: a comprehensive review. Front Cell Infect Microbiol. 2025;15:1504223. https:\/\/doi.org\/10.3389\/fcimb.2025.1504223.","journal-title":"Front Cell Infect Microbiol"},{"key":"4889_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107596","volume":"212","author":"J Wang","year":"2025","unstructured":"Wang J, Tao X, Liu Z, Yan Y, Cheng P, Liu B, et al. Noncoding RNAs in sepsis-associated acute liver injury: roles, mechanisms, and therapeutic applications. Pharmacol Res. 2025;212:107596. https:\/\/doi.org\/10.1016\/j.phrs.2025.107596.","journal-title":"Pharmacol Res"},{"issue":"5","key":"4889_CR9","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/hep.30700","volume":"70","author":"C Li","year":"2019","unstructured":"Li C, Jin Y, Wei S, Sun Y, Jiang L, Zhu Q, et al. Hippo signaling controls NLR family pyrin domain containing 3 activation and governs immunoregulation of mesenchymal stem cells in mouse liver injury. Hepatology. 2019;70(5):1714\u201331. https:\/\/doi.org\/10.1002\/hep.30700.","journal-title":"Hepatology"},{"issue":"4","key":"4889_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","volume":"71","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lu T, Zhang C, Xu J, Xue Z, Busuttil RW, et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol. 2019;71(4):719\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2019.05.029.","journal-title":"J Hepatol"},{"issue":"8064","key":"4889_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41586-025-08778-6","volume":"641","author":"MDM Rigual","year":"2025","unstructured":"Rigual MDM, Angulo-Aguado M, Zagorac S, Alvarez-Diaz R, Benitez-Mondejar M, Yi F, et al. Macrophages harness hepatocyte glutamate to boost liver regeneration. Nature. 2025;641(8064):1005\u201316. https:\/\/doi.org\/10.1038\/s41586-025-08778-6.","journal-title":"Nature"},{"issue":"3","key":"4889_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/HEP.0000000000000773","volume":"81","author":"S Zhang","year":"2025","unstructured":"Zhang S, Sun Z, Chen Z, Bi Y, Wei S, Mao Z, Jin J, Ding Y, Wang W. Endothelial YAP\/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury. Hepatology. 2025;81(3):888\u2013902. https:\/\/doi.org\/10.1097\/HEP.0000000000000773.","journal-title":"Hepatology"},{"issue":"1","key":"4889_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2486515","volume":"17","author":"JJ Hu","year":"2025","unstructured":"Hu JJ, Deng F, Sun QS, Xiong QM, Min Y, Feng SY, et al. Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate. Gut Microbes. 2025;17(1):2486515. https:\/\/doi.org\/10.1080\/19490976.2025.2486515.","journal-title":"Gut Microbes"},{"issue":"1","key":"4889_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18\u201335. https:\/\/doi.org\/10.1038\/ajg.2016.517.","journal-title":"Am J Gastroenterol"},{"key":"4889_CR15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i14.104584","author":"T-W Wang","year":"2025","unstructured":"Wang T-W, Zhou L-L, Yuan J, Zhou W-X, Wang H-R, Yu T-T, et al. Study of the relationship between iron metabolism disorders and sepsis-associated liver injury: a prospective observational study. World J Gastroenterol. 2025. https:\/\/doi.org\/10.3748\/wjg.v31.i14.104584.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4889_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/epidemiologia5030032","volume":"5","author":"L La Via","year":"2024","unstructured":"La Via L, Sangiorgio G, Stefani S, Marino A, Nunnari G, Cocuzza S, et al. The global burden of sepsis and septic shock. Epidemiologia (Basel). 2024;5(3):456\u201378. https:\/\/doi.org\/10.3390\/epidemiologia5030032.","journal-title":"Epidemiologia (Basel)"},{"issue":"1","key":"4889_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04176-w","volume":"26","author":"C Lorencio Cardenas","year":"2022","unstructured":"Lorencio Cardenas C, Yebenes JC, Vela E, Cleries M, Sirvent JM, Fuster-Bertolin C, et al. Trends in mortality in septic patients according to the different organ failure during 15 years. Crit Care. 2022;26(1):302. https:\/\/doi.org\/10.1186\/s13054-022-04176-w.","journal-title":"Crit Care"},{"issue":"16","key":"4889_CR18","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1097\/CM9.0000000000003673","volume":"138","author":"L Wang","year":"2025","unstructured":"Wang L, Chen J, Zhou X, China National Critical Care Quality Control Centre, G. Multiple organ dysfunction and the mortality in sepsis: a multicenter retrospective study. Chin Med J (Engl). 2025;138(16):2037\u20139. https:\/\/doi.org\/10.1097\/CM9.0000000000003673.","journal-title":"Chin Med J (Engl)"},{"issue":"13","key":"4889_CR19","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","volume":"318","author":"C Rhee","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. JAMA. 2017;318(13):1241\u20139. https:\/\/doi.org\/10.1001\/jama.2017.13836.","journal-title":"JAMA"},{"issue":"4","key":"4889_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/CCM.0000000000002262","volume":"45","author":"BB Whiles","year":"2017","unstructured":"Whiles BB, Deis AS, Simpson SQ. Increased time to initial antimicrobial administration is associated with progression to septic shock in severe sepsis patients. Crit Care Med. 2017;45(4):623\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000002262.","journal-title":"Crit Care Med"},{"key":"4889_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL. The Hippo Pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111829.","journal-title":"Annu Rev Biochem"},{"key":"4889_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","volume":"16","author":"JH Driskill","year":"2021","unstructured":"Driskill JH, Pan D. The Hippo Pathway in liver homeostasis and pathophysiology. Annu Rev Pathol. 2021;16:299\u2013322. https:\/\/doi.org\/10.1146\/annurev-pathol-030420-105050.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"4889_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A. 2010;107(4):1437\u201342. https:\/\/doi.org\/10.1073\/pnas.0911427107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4889_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s41232-022-00235-5","volume":"42","author":"M Pibiri","year":"2022","unstructured":"Pibiri M, Simbula G. Role of the Hippo pathway in liver regeneration and repair: recent advances. Inflamm Regen. 2022;42(1):59. https:\/\/doi.org\/10.1186\/s41232-022-00235-5.","journal-title":"Inflamm Regen"},{"issue":"4","key":"4889_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107208","volume":"300","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wei W, Tu S, Liang B, Li C, Li Y, et al. Upregulation of CYR61 by TGF-\u03b2 and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. J Biol Chem. 2024;300(4):107208. https:\/\/doi.org\/10.1016\/j.jbc.2024.107208.","journal-title":"J Biol Chem"},{"issue":"5","key":"4889_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16(5):425\u201338. https:\/\/doi.org\/10.1016\/j.ccr.2009.09.026.","journal-title":"Cancer Cell"},{"issue":"1","key":"4889_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7(1):376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"783","key":"4889_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adc9656","volume":"16","author":"VS Meli","year":"2023","unstructured":"Meli VS, Veerasubramanian PK, Downing TL, Wang W, Liu WF. Mechanosensation to inflammation: roles for YAP\/TAZ in innate immune cells. Sci Signal. 2023;16(783):eadc9656. https:\/\/doi.org\/10.1126\/scisignal.adc9656.","journal-title":"Sci Signal"},{"issue":"1","key":"4889_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41419-024-06448-5","volume":"15","author":"A Kwon","year":"2024","unstructured":"Kwon A, Lee NY, Yu JH, Choi MG, Park J, Koo JH. Mitochondrial stress activates YAP\/TAZ through RhoA oxidation to promote liver injury. Cell Death Dis. 2024;15(1):51. https:\/\/doi.org\/10.1038\/s41419-024-06448-5.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4889_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jcmgh.2023.01.002","volume":"15","author":"Y Yang","year":"2023","unstructured":"Yang Y, Ni M, Zong R, Yu M, Sun Y, Li J, et al. Targeting Notch1-YAP circuit reprograms macrophage polarization and alleviates acute liver injury in mice. Cell Mol Gastroenterol Hepatol. 2023;15(5):1085\u2013104. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.01.002.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"4889_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","volume":"71","author":"Y Liu","year":"2019","unstructured":"Liu Y, Lu T, Zhang C, Xu J, Xue Z, Busuttil RW, et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol. 2019;71(4):719\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2019.05.029.","journal-title":"J Hepatol"},{"key":"4889_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1505117","volume":"16","author":"W Xuan","year":"2025","unstructured":"Xuan W, Song D, Hou J, Meng X. Regulation of Hippo-YAP1\/TAZ pathway in metabolic dysfunction-associated steatotic liver disease. Front Pharmacol. 2025;16:1505117. https:\/\/doi.org\/10.3389\/fphar.2025.1505117.","journal-title":"Front Pharmacol"},{"issue":"13","key":"4889_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33370","volume":"10","author":"Y Xue","year":"2024","unstructured":"Xue Y, Lu J, Liu Y, Gao Y, Gong Y, Yang Y, et al. Dihydroartemisinin modulated arachidonic acid metabolism and mitigated liver inflammation by inhibiting the activation of 5-LOX and COX-2. Heliyon. 2024;10(13):e33370. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33370.","journal-title":"Heliyon"},{"issue":"1","key":"4889_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12879-023-08387-6","volume":"23","author":"Q Guo","year":"2023","unstructured":"Guo Q, Qu P, Cui W, Liu M, Zhu H, Chen W, Sun N, Geng S, Song W, Li X, Lou A. Organism type of infection is associated with prognosis in sepsis: an analysis from the MIMIC-IV database. BMC Infect Dis. 2023;23(1):431. https:\/\/doi.org\/10.1186\/s12879-023-08387-6.","journal-title":"BMC Infect Dis"},{"key":"4889_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jcrc.2016.11.036","volume":"38","author":"A Moskowitz","year":"2017","unstructured":"Moskowitz A, Omar Y, Chase M, Lokhandwala S, Patel P, Andersen LW, et al. Reasons for death in patients with sepsis and septic shock. J Crit Care. 2017;38:284\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2016.11.036.","journal-title":"J Crit Care"},{"issue":"3","key":"4889_CR36","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"J Xie","year":"2020","unstructured":"Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48(3):e209\u201318. https:\/\/doi.org\/10.1097\/CCM.0000000000004155.","journal-title":"Crit Care Med"},{"issue":"1","key":"4889_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22987-3","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang D, Zhang Y, Xu X, Wu J, Peng Y, Li J, et al. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3. Nat Commun. 2021;12(1):2674. https:\/\/doi.org\/10.1038\/s41467-021-22987-3.","journal-title":"Nat Commun"},{"issue":"1","key":"4889_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCRESAHA.118.313143","volume":"123","author":"Y Lv","year":"2018","unstructured":"Lv Y, Kim K, Sheng Y, Cho J, Qian Z, Zhao YY, et al. YAP controls endothelial activation and vascular inflammation through TRAF6. Circ Res. 2018;123(1):43\u201356. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313143.","journal-title":"Circ Res"},{"issue":"19","key":"4889_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70156","volume":"28","author":"X Yang","year":"2024","unstructured":"Yang X, Duan H, Li S, Zhang J, Dong L, Ding J, et al. Yap1 alleviates sepsis associated encephalopathy by inhibiting hippocampus ferroptosis via maintaining mitochondrial dynamic homeostasis. J Cell Mol Med. 2024;28(19):e70156. https:\/\/doi.org\/10.1111\/jcmm.70156.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4889_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13578-022-00902-7","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Zhu Q, Li R, Zhang J, Ye X, Li X. YAP1 protects against septic liver injury via ferroptosis resistance. Cell Biosci. 2022;12(1):163. https:\/\/doi.org\/10.1186\/s13578-022-00902-7.","journal-title":"Cell Biosci"},{"issue":"1","key":"4889_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51314-9","volume":"15","author":"F Petermann-Rocha","year":"2024","unstructured":"Petermann-Rocha F, Zhou Z, Mathers JC, Celis-Morales C, Raubenheimer D, Sattar N, et al. Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence. Nat Commun. 2024;15(1):6880. https:\/\/doi.org\/10.1038\/s41467-024-51314-9.","journal-title":"Nat Commun"},{"issue":"19","key":"4889_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199715","volume":"26","author":"W Choi","year":"2025","unstructured":"Choi W, Woo GH, Kwon TH, Jeon JH. Obesity-driven metabolic disorders: the interplay of inflammation and mitochondrial dysfunction. Int J Mol Sci. 2025;26(19):9715. https:\/\/doi.org\/10.3390\/ijms26199715.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4889_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07369-3","volume":"23","author":"M Fei","year":"2025","unstructured":"Fei M, Xu Y, Jin P, Wang Y, Zhou M. Mitochondrial dysfunction in sepsis-induced liver injury: from pathophysiology to preclinical therapeutic targets. J Transl Med. 2025;23(1):1339. https:\/\/doi.org\/10.1186\/s12967-025-07369-3.","journal-title":"J Transl Med"},{"key":"4889_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1575554","volume":"16","author":"X Xu","year":"2025","unstructured":"Xu X, Yang T, An J, Li B, Dou Z. Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies. Front Immunol. 2025;16:1575554. https:\/\/doi.org\/10.3389\/fimmu.2025.1575554.","journal-title":"Front Immunol"},{"issue":"7","key":"4889_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/00325481.2024.2388021","volume":"136","author":"L Desposito","year":"2024","unstructured":"Desposito L, Bascara C. Review: sepsis guidelines and core measure bundles. Postgrad Med. 2024;136(7):702\u201311. https:\/\/doi.org\/10.1080\/00325481.2024.2388021.","journal-title":"Postgrad Med"},{"issue":"11","key":"4889_CR46","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"issue":"4","key":"4889_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/ALN.0000000000003655","volume":"134","author":"RM Pino","year":"2021","unstructured":"Pino RM, Singh J. Appropriate clinical use of lactate measurements. Anesthesiology. 2021;134(4):637\u201344. https:\/\/doi.org\/10.1097\/ALN.0000000000003655.","journal-title":"Anesthesiology"},{"key":"4889_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/1178633719862776","volume":"12","author":"J Villar","year":"2019","unstructured":"Villar J, Short JH, Lighthall G. Lactate predicts both short- and long-term mortality in patients with and without sepsis. Infect Dis (Auckl). 2019;12:1178633719862776. https:\/\/doi.org\/10.1177\/1178633719862776.","journal-title":"Infect Dis (Auckl)"},{"issue":"3","key":"4889_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MCC.0b013e3283532b8a","volume":"18","author":"BM Fuller","year":"2012","unstructured":"Fuller BM, Dellinger RP. Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care. 2012;18(3):267\u201372. https:\/\/doi.org\/10.1097\/MCC.0b013e3283532b8a.","journal-title":"Curr Opin Crit Care"},{"issue":"Pt 2","key":"4889_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113492","volume":"143","author":"W Xu","year":"2024","unstructured":"Xu W, Hou H, Yang W, Tang W, Sun L. Immunologic role of macrophages in sepsis-induced acute liver injury. Int Immunopharmacol. 2024;143(Pt 2):113492. https:\/\/doi.org\/10.1016\/j.intimp.2024.113492.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4889_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01978-z","volume":"17","author":"H Yu","year":"2020","unstructured":"Yu H, Cao X, Li W, Liu P, Zhao Y, Song L, et al. Targeting connexin 43 provides anti-inflammatory effects after intracerebral hemorrhage injury by regulating YAP signaling. J Neuroinflammation. 2020;17(1):322. https:\/\/doi.org\/10.1186\/s12974-020-01978-z.","journal-title":"J Neuroinflammation"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04889-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:33:28Z","timestamp":1782862408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04889-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4889"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04889-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in conformance with the Declaration of Helsinki ethical guidelines and was approved by the Northern Jiangsu People\u2019s Hospital (2024ky293). The Clinical Trial Number is ChiCTR2500105578. Informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"393"}}